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Abstract
Individuals with nonsyndromic congenital retinal nonattachment (NCRNA) are totally blind from 
birth. The disease afflicts ~1% of Kurdish people living in a group of neighboring villages in 
North Khorasan, Iran. We show NCRNA is caused by a 6523bp deletion that spans a remote cis 
regulatory element 20 kb upstream from ATOH7 (Math5), a bHLH transcription factor gene 
required for retinal ganglion cell (RGC) and optic nerve development. In humans, the absence of 
RGCs stimulates massive neovascular growth of fetal blood vessels within the vitreous, and early 
retinal detachment. The remote ATOH7 element appears to act as a secondary or ‘shadow’ 
transcriptional enhancer. It has minimal sequence similarity to the primary enhancer, which is 
close to the Atoh7 promoter, but drives transgene expression with an identical spatiotemporal 
pattern in the mouse retina. The human transgene also functions in zebrafish, reflecting deep 
evolutionary conservation. These dual enhancers may reinforce Atoh7 expression during early 
critical stages of eye development when retinal neurogenesis is initiated.
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INTRODUCTION
The vertebrate neural retina develops during embryogenesis from multipotent progenitors in 
the optic cup. These cells exit mitosis and differentiate to form photoreceptors, interneurons, 
Müller glia, and retinal ganglion cells (RGCs) through the actions of intrinsic and extrinsic 
factors1. Seven major cell types emerge from the progenitor pool in a relatively fixed order, 
with overlapping birthdates, and differentiate to form a highly laminar structure that detects 
and processes visual information. Histogenesis starts in the central retina and spreads to the 
periphery over several days to weeks, depending on the species. Ganglion cells are the first-
born retinal neurons in all vertebrates and occupy the innermost nuclear layer. Their axons 
comprise the optic nerves, which convey all visual information from the eyes to the brain. In 
mice, RGC genesis begins on embryonic day E11 and peaks around E13. In humans, RGCs 
are born between the 5th and 11th weeks of gestation. In addition to neurons, the retina 
contains astrocytes, which originate from a separate progenitor pool in the optic stalk. These 
enter the eye during late gestation, migrate across the inner retinal surface, and retain mitotic 
potential2.
Intrinsic factors controlling retinal histogenesis have been defined in large part through 
analysis of mouse genetic models. An archetypal example is the proneural bHLH (basic 
helix-loop-helix) transcription factor Atoh7 (Math5), a homolog of Drosophila Atonal3. The 
Atoh7 gene is transiently expressed in newly post-mitotic precursors, beginning with the 
onset of neurogenesis4. Atoh7 mutant mice lack optic nerves and have a >95% reduction in 
ganglion cell abundance5,6. No other cell type is missing. Their eyes detect light and process 
visual information within the retina but transmit few, if any, signals to the brain7. An 
orthologous ath5 mutation was identified in the lakritz zebrafish8. In mouse Cre-lox lineage 
experiments, Atoh7+ precursors give rise to 5% of cells in the normal adult retina, but only a 
fraction of these precursors develop as RGCs4,9. Atoh7 thus acts as a competence factor for 
RGC fate. Differentially expressed mRNAs have been identified in mutant retinas10, but the 
exact mechanism of Atoh7 action is incompletely understood.
The mammalian retina is nourished by two vascular systems. The inner two-thirds is 
supplied by the central artery, which enters the eye through the optic nerve and branches to 
form surface and deep capillary beds. The outer retina is oxygenated by diffusion from the 
surrounding choriocapillaris. Both systems derive from the fetal circulation11,12. In the 
embryo, inner hyaloid and outer ciliary vessels envelop the optic cup, anastomose across the 
rim, and fill the vitreous space. Starting at P0 in mice, vessels surrounding the lens regress 
through a branch-wise process of apoptosis, and the hyaloid trunk is remodeled to form the 
central retinal artery. In humans, these events occur during late gestation and early postnatal 
life13.
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Many forms of hereditary blindness are caused by mutations in genes required for retinal 
cell maintenance or physiology, leading to slow or rapidly progressing degeneration14. A 
smaller number of diseases involve genes such as CRX or NR2E3, which are required for 
photoreceptor differentiation15. As yet, no human retinal disorder has been specifically 
associated with defects in fate determination of non-photoreceptor cell types. Congenital 
retinal vascular disorders are also major causes of blindness worldwide. In retinopathy of 
prematurity (ROP), familial exudative vitreoretinopathy (FEVR) and persistent hyperplasia 
of the primary vitreous (PHPV), ischemia and angiogenic signaling defects are the primary 
stimulus for pathological retinal neovascularization11.
Congenital retinal nonattachment is a severe form of blindness, with no detection of light 
from birth16. The retina is partially or completely separated from the posterior globe, and 
there is typically a fibrovascular mass behind the lens. The disease is heterogeneous, with a 
variety of clinical and histological anomalies involving the retina and blood vessels in one or 
both eyes. In some patients, the disease occurs with systemic malformations, but there is no 
consistent association. Sporadic and familial cases have been reported17. A nonsyndromic 
hereditary form (NCRNA) is common in North Khorasan, Iran, among descendants of a 
Kurdish founder population, and it is inherited as an autosomal recessive trait with complete 
penetrance18. The locus was mapped by SSLP linkage and haplotype analysis to a 0.6–1.5 
cM region on chromosome 10q21, but the causative mutation and pathogenic mechanism are 
unknown19,20. In principle, the disease could arise from an intrinsic flaw in neuronal or 
vascular development.
In this report, we show that blind NCRNA patients lack optic nerves, which prevents light 
perception and profoundly affects the development of retinal vasculature. Our data suggest 
that NCRNA is caused by deletion of conserved DNA sequences that appear to control 
ATOH7 expression in early neuroretinal precursors. Finally, we show that the deleted 
sequences have properties consistent with a duplicate or ‘shadow’ enhancer21, including: [1] 
an identical pattern of transcriptional activation as the primary Atoh7 enhancer, [2] a remote 
genomic location, [3] a comparatively recent evolutionary origin and [4] conserved 
biological activity among vertebrates. NCRNA is thus a Mendelian is order that disrupts the 
intrinsic mechanism of retinal cell fate determination.
RESULTS
Nonsyndromic congenital retinal nonattachment (NCRNA)
This autosomal recessive disorder (MIM221900) was first described in a large 
consanguineous Kurdish family that traces its ancestry for nine generations (Fig. 1g). The 
founders were dislocated centuries ago from Kurdistan to North Khorasan province in 
eastern Iran, during the Safavid Dynasty22, and their descendants remained relatively 
isolated, linguistically, culturally and genetically, from the main Persian population until 
recent years. The disease afflicts 1.1% of the population in four neighboring villages, with 
an estimated carrier frequency of 18% for the NCRNA allele18.
The affected individuals are totally blind, with no perception of light. Their eyes exhibit 
leukocoria (white pupils), esotropia (misalignment with inward deviation), and a continuous 
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pendular nystagmus (jerky eye movements) (Fig. 1a–f). The pupils have no direct or 
consensual light reaction. In three-quarters of eyes examined, the anterior chambers were 
relatively shallow, but there was no consistent elevation of intraocular pressure. During a 
previous study18, B-scan ultrasonography and serial fundoscopic examinations revealed 
formation of a dense mass behind the lens in each eye, with complete opacification of the 
vitreous by four months (Fig. 1e,f). There is also a slowly progressive corneal clouding, 
consistent with endothelial blood staining23, which was evident to some extent in all adults 
examined. This develops over several years, is more severe in the inferior part of the cornea 
(Fig. 1b), and may occur with iridocorneal adhesions. No other sensory or neurological 
defects have been detected in the blind individuals. Their auditory, olfactory, endocrine and 
intellectual functions are intact, and they have normal developmental milestones. They have 
no systemic or other vascular abnormalities. Together, these clinical findings suggest 
bilateral persistence of the fetal blood vessels, with complete congenital detachment of the 
neural retina, and intravitreal vascular proliferation during infancy. The obligate 
heterozygotes are clinically normal. They have good vision, with no structural or functional 
eye pathology.
Optic nerve aplasia in NCRNA
Given the complete blindness, congenital nystagmus, and absent pupillary light reflexes, we 
investigated optic nerve defects as the primary anatomical basis for NCRNA pathology. 
Nystagmus is common in children with severe optic nerve malformations24, and it is thought 
to arise from unbalanced sensory input to central autonomic centers controlling gaze, and a 
failure to calibrate oculomotor systems. The pupillary light reflex is triggered by rare 
photosensitive RGCs, which relay signals to the cortex of the olivary pretectal nuclei via the 
optic nerves. Proximity of the NCRNA region to ATOH7 also raised the possibility of optic 
nerve involvement. Atoh7 mutant mice have essentially no pupillary reflex25, and significant 
retinovascular abnormalities26, although retinal detachments are rare.
In the original fundoscopic exams of one affected infant prior to vitreal opacification, the 
status of the optic discs could not be determined18. To characterize the optic nerves 
anatomically, we performed orbital MRI exams on one adult NCRNA patient (Fig. 2a–c,f). 
As expected, this study showed heterogeneous consolidation of the vitreous compartments, 
consistent with complete retinal detachment and a retrolental fibrovascular mass in each eye. 
The sclerae (white fibrous outer layer of the eye globes), lens, extraocular muscles, 
retrobulbar fat and adnexa (lacrimal glands and other accessory visual structures) appeared 
relatively normal, and there were no anatomical defects in the anterior brain. In contrast, the 
optic nerves and chiasm were absent or greatly attenuated in multiple views. However, 
because the oculomotor and ciliary nerves and ophthalmic blood vessels were difficult to 
resolve within the orbital cones, we cannot exclude the presence of small atrophic optic 
nerves in these patients, similar to residual RGCs reported in some Atoh7 mutant mice27.
Identification of the NCRNA mutation
The critical region spans 1639kb, from D10S1670 to D10S1418, and overlaps 14 positional 
candidate genes, including ATOH7 (Fig. 3a). We therefore tested blind (rr) and heterozygous 
(Rr) family members for mutations in the ATOH7 transcription unit28,29 and known 
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regulatory elements within 5.5kb of the initiation site, by sequencing multiple PCR 
amplicons (Supplementary Fig. 1, Supplementary Table 1). The proximal 1.8kb upstream 
segment has been conserved during vertebrate evolution28 and is sufficient to drive reporter 
transgene expression in embryonic mouse retinas with a pattern similar to the Math5-lacZ 
knock-in allele30,31.
No sequence changes were found in the ATOH7 gene or proximal upstream region 
compared to the NCBI reference genome or known variants. Likewise, no mutation was 
found in any of the 13 other genes in the nonrecombinant interval, including SIRT1, which 
has a major retinal dysgenesis phenotype in mutant mice (Supplementary Table 2).
To screen for remote structural changes in the ATOH7 region, we amplified single-copy 
DNA products from the 74 kb intergenic segment delimited by flanking genes PBLD 
(phenazine biosynthesis-like domain) and MYPN (myopalladin). This analysis revealed a 
deletion of six adjacent amplicons out of 17 distributed across the region, in samples from 
blind individuals (rr) compared to non-carrier relatives (RR) (Fig. 3, Supplementary Table 
3). To verify this result and define endpoints, we performed multiple PCRs with primers 
flanking the deletion, and amplified a nested set of junctional products from NCRNA 
samples (Supplementary Fig. 2). The deletion spans 6523bp, with 5bp microhomology at the 
endpoints (Fig. 4b). It is located 21.7 to 15.2kb upstream of the ATOH7 transcription start 
site and 28.8 to 35.3kb downstream from the 3′ end of PBLD (Fig. 3c). We then genotyped 
all available samples from the pedigree (n =150), including individuals who were not part of 
the original linkage studies, using a triplex strategy to amplify wild-type (+) and NCRNA 
(Δ) alleles simultaneously (Fig. 4a). The results were completely concordant with phenotype 
data. All 31 blind individuals were homozygous for the deletion (ΔΔ), and all 119 sighted 
relatives were homozygous for the wild-type allele (++, n = 39) or heterozygous for the 
deletion (Δ+, n = 80, including known obligate carriers). The correlation is highly significant 
(χ2 = 150.17 for df = 3, giving P = 1.20 × 10−32).
To evaluate the small possibility of a second, coincidental deletion or duplication in the 
nonrecombinant region, we performed high-resolution SNP (single nucleotide 
polymorphism) analysis on six DNA samples from the NCRNA pedigree, including two 
blind patients and two obligate carriers (Supplementary Fig. 3). This analysis detected the 
deletion 20kb upstream from ATOH7 (spanning rs385145) but no further abnormalities. 
Unexpectedly, DNA from one blind individual (10877) was heterozygous for SNP markers 
centromeric to MYPN, revealing a novel recombinant disease haplotype. The underlying 
crossover narrows the critical region to 713kb and formally excludes four of the original 
candidate genes. Although an occult point mutation is theoretically possible, the combined 
genetic, clinical and functional data strongly support a causal relationship between the 6.5 
kb deletion and NCRNA disease.
The NCRNA deletion removes a cis regulatory element
Since heterozygotes are healthy, a loss of gene function is the most logical pathogenic 
mechanism. The deleted region contains no annotated exons, cDNAs or ESTs (Fig. 3c). In 
principle, the 6.5 kb deletion could affect expression of ATOH7, PBLD or a more distant 
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gene. Dysregulation of PBLD is an unlikely explanation for NCRNA disease pathology, 
because it is not expressed in the developing eye (see below).
To rigorously survey the expression of flanking genes, we performed RT-PCR analysis in 
mice (Supplementary Fig. 4). Although a low level of Mypn mRNA was detected in the fetal 
eye, only Atoh7 is specifically expressed at high levels. Because EST and 5′RACE data 
provide no evidence for an alternative upstream exon or mRNA splicing29, these results are 
most consistent with an enhancer mutation affecting the transcriptional regulation of 
ATOH7.
The NCRNA deletion removes a cluster of three conserved noncoding elements (CNEs) 
with a level of nucleotide identity among mammals that is comparable to the ATOH7 coding 
and proximal regulatory regions (Fig. 3c). To test the function of these CNEs in vivo, we 
generated transgenic mice in which 3.8 kb human genomic DNA from the deletion was 
joined to a minimal β-globin promoter (BG) and red fluorescent protein (nuclear Cherry) 
reporter (Fig. 5). This 3034-BGnCherry transgene was specifically expressed in the 
developing retina in 5 of 6 founder embryos and 2 of 3 stable lines. No activity was detected 
from the remaining two integration events. The restricted spatiotemporal pattern matches the 
Math5-lacZ knock-in allele, beginning at E11.5 with the onset of retinal neurogenesis and 
continuing to P1 in newly post-mitotic retinal precursors4,5 (Fig. 6a,b,e–). No overlap was 
observed between nuCherry and the S-phase marker BrdU or the M-phase marker PH3 (Fig. 
6c,d,f–h). Together, our data suggest the deleted CNEs may act as a transcriptional 
enhancer. These CNEs are further upstream from the ATOH7 coding sequence than 
previously studied regions32. Although not tested directly, the NCRNA deletion may impair 
the level or timing of ATOH7 expression.
Functional comparison of genomic enhancers near ATOH7
The mammalian ATOH7 region contains two broad regulatory units–a primary enhancer 
located within 2kb of the promoter, which has been characterized in mouse genomic 
DNA30,31, and the remote cluster of CNEs that is deleted in the NCRNA pedigree (Fig. 5). 
To directly compare their activities, we crossed 3034-BGnCherry and Math5-GFP mice, 
which carry reporters controlled by the human remote and mouse primary enhancers 
respectively, and examined nuCherry and GFP expression in double transgenic embryos by 
fluorescence and confocal microscopy, and flow cytometry (Fig. 7, Supplementary Fig. 5). 
These patterns were essentially overlapping, spatially and temporally, despite the fact that 
regulatory elements in the transgenes were derived from different species, that the primary 
and remote regulatory units have little sequence similarity to each other (Supplementary 
Figs. 6–8), and that Atoh7 is only transcribed for a few hours in each cell, beginning after 
terminal M phase. Flow analysis of dissociated E14.5 neural retinas revealed a single 
population of cells, comprising 40% of the total, that coexpress nuCherry and GFP (and 
presumably Atoh7) (Fig. 7c). There were few single-positive cells, which could arise from 
differences in folding time and perdurance of the reporter proteins. Thus, despite devastating 
clinical consequences of the NCRNA deletion (Figs. 1–2), the proximal and remote 
enhancers appear redundant in their ability to direct transcription in a transgenic context.
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Unlike the coding region, which is deeply conserved among vertebrates, there is limited 
sequence homology between the remote enhancer, in mouse or human DNA, and the 
corresponding region upstream of Atoh7 (ath5) in teleosts (Supplementary Figs.7–8). 
Indeed, the syntenic block containing Atoh7 has been significantly disrupted by evolutionary 
chromosome rearrangements with breakpoints close to the promoter (Supplementary Fig. 6). 
To test enhancer function in a divergent species, we generated 3034-BGnCherry zebrafish 
carrying the same nuCherry reporter transgene. In these fish, nuCherry expression was 
restricted to the developing retina and correlated with the onset of neurogenesis (Fig. 8a,b). 
Moreover, 3034-BGnCherry fully overlapped expression of the ath5:GFP transgene33 
which contains 7kb zebrafish Atoh7 regulatory DNA (Fig. 8c,d and Supplementary Fig. 9). 
Although distantly related by structure and ancestry, the human remote enhancer is 
appropriately recognized by transcriptional machinery in the teleost retina and is thus 
functionally conserved.
DISCUSSION
In this paper, we identify an ATOH7 regulatory deletion as the probable cause of 
nonsyndromic congenital retinal nonattachment, a Mendelian disorder of cell fate 
determination. Although circumstantial, this conclusion is based on the most parsimonious 
interpretation of concordant phenotypic, genetic, transgene expression and evolutionary 
data. Since Atoh7 controls development of the first-born retinal neurons (RGCs), the deleted 
enhancer, and the proximal regulatory region, appear to be the principal sites in the 
mammalian genome responsible for initiating retinal neurogenesis.
NCRNA disease
Although relatively rare worldwide, NCRNA is common in certain geographic areas, and 
other families have been reported with this disease16,17. Clinically related malformations, 
such as retinal dysplasia, congenital falciform folds and PHPV, have been described 
histologically, and may coexist with retinal nonattachment in the same pedigree or 
contralateral eye. To our knowledge, optic nerve aplasia has not been previously associated 
with retinal nonattachment. Our findings provide a basis for molecular genetic analysis of 
these disorders and carrier detection in the Khorasani pedigree.
Coupled neurovascular development in the retina
The ocular pathology in NCRNA patients resembles the phenotype of Atoh7 mutant mice 
beyond the absence of optic nerves. In normal mice, retinal vascular development occurs 
between birth and P14, with spreading of surface vessels from the central artery to the ora 
serrata, elaboration of two deep vascular plexi, and coordinated regression of the fetal 
hyaloid network12. In Atoh7 mutants, there is complete agenesis of the intrinsic retinal 
vasculature26. Instead, the fetal vessels persist after birth and collapse upon the retinal 
surface, where they penetrate and ramify in an irregular pattern. These abnormal vessels are 
perfused by cilioretinal arteries and the remnant hyaloid trunk, and are prone to hemorrhage. 
A comparable but less severe neovascularization has been noted in Bst/+ mice and some 
human sporadic optic nerve aplasia cases34, and may reflect a general deficiency of RGC 
paracrine factors that control retinal angiogenesis.
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In NCRNA patients, the pathogenic sequence of events is likely to be similar to that in 
Atoh7 mutant mice, except that the persistent fetal blood vessels appear to proliferate more 
dramatically during infancy, causing complete perinatal detachment of the retina. This may 
occur during or shortly after neurogenesis, since the pathology is apparent at birth, and it 
may have a tractional basis, involving fibrovascular strands between the retina, posterior 
lens and hyaloid vessels. Indeed, vascular traction is thought to underlie the prevalence of 
juvenile detachments in patients with ROP, PHPV and FEVR. RGC axons comprising the 
nerve fiber layer may also stabilize the retina mechanically. The difference between mouse 
Atoh7 and human NCRNA phenotypes may reflect the large disparity in scale between 
species for several parameters: [1] the size of the eye globe compared to the fixed distance 
for O2 diffusion and thickness of the neuroretinal shell; [2] the relative volume of the lens 
and vitreous chamber; [3] the exposure of the retina to mechanical forces; and [4] the 
surface area requiring perfusion. Consequently, the hypoxia experienced by cells in the 
newborn retina, and the extent of the proliferative neovascular response, may be 
significantly greater in NCRNA patients compared to Atoh7 mutant mice, and this may 
promote retinal detachment. There are also important differences in retinal structure and 
timing of vascular development between humans and mice, which may affect NCRNA 
pathogenesis13.
Regardless of these differences, the vascular phenotype in both species is a secondary 
consequence of the absence of RGCs, since Atoh7 expression is limited to neurons. 
Although the molecular pathways are not fully defined, ganglion cells are known to 
stimulate migration of retinal astrocytes from the optic stalk, which promotes the normal 
program of vascularization12. These events are mediated by signaling factors such as Shh, 
Pdgfa, Vegf and Ndp2. In this way, the pathogenesis of NCRNA further highlights the 
interdependence between neural and vascular development.
The profusion of vitreal blood vessels in NCRNA resembles the vascular events in 
retinopathy of prematurity, a major form of childhood blindness35. Although multiple risk 
factors have been identified, ROP is primarily stimulated by retinal ischemia during 
postnatal development, with an excessive angiogenic response. The new vessels create a 
fibrovascular ridge, near the equator of the globe, with a risk of folding and tractional 
detachment. The time course for retrolental fibroplasia in NCRNA and ROP progression are 
similar18,36.
In children and adults with NCRNA, recurrent intravitreal hemorrhages may communicate 
with the anterior chamber, causing chronic corneal blood staining, a local hemosiderin 
reaction. Although this effect has not been demonstrated histologically in Atoh7 mutants, 
hyphemas do occur in these mice26.
Conserved role for ATOH7 in retinogenesis
The role of atonal bHLH proteins in generating the first retinal neurons has been conserved 
during vertebrate and invertebrate evolution5,37. In the Drosophila eye imaginal disc, Atonal 
specifies R8 cells, which induce formation of photoreceptors R1–R7 through a succession of 
cell-cell interactions. Consequently, in ato mutant flies, all of these dependent cell types are 
missing. In Atoh7 mutant mice and lakritz zebrafish, the absence of ganglion cells does not 
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trigger a similar neurogenic catastrophe. However, the loss of RGC inductive signals does 
cause a major retinovascular failure in humans with NCRNA disease.
The signals that initiate retinal neurogenesis converge upon Atoh7 transcriptional enhancers. 
Several extrinsic factors have been implicated, which may stimulate (FGF), suppress 
(GDF11) or modulate (SHH) Atoh7 expression (Supplementary Notes). Likewise, a variety 
of homeodomain and bHLH proteins appear to act directly upstream, including Pax6 and 
Neurog23,32,38. Functional binding sites have been identified within the bipartite 1.8 kb 
primary enhancer for mouse, Xenopus and chicken Atoh730–32,39 and are predicted in the 
most conserved portions of the remote enhancer (Supplementary Fig. 7d,e). These two DNA 
segments drive expression in the developing retinas of multiple species in an appropriate 
spatiotemporal pattern for Atoh7, despite differences in timing with respect to cell cycle exit. 
Mouse Atoh7 is expressed after terminal M phase4, whereas zebrafish ath5 is activated 
during G2 phase of the last cell division, such that every ath5+ cell gives rise to two 
daughters33 (Supplementary Fig. 9d,e). In each case, regulatory protein complexes are likely 
to assemble on the enhancer chromatin in mitotic progenitors prior to Atoh7 transcription, in 
a latent configuration, defining the RGC competence state1. The factors that mark these cells 
for terminal division are unknown.
The shadow enhancer and optic nerve development
On the basis of our findings, we speculate that the remote CNEs may function as a ‘shadow’ 
or secondary enhancer for ATOH7. This class of regulatory elements are thought to 
reinforce, refine or stabilize the effects of primary enhancers and may serve as vehicles for 
evolutionary change21,40. First, the NCRNA element is located ~20kb from the primary 
ATOH7 enhancer, which is close to the mRNA initiation site, and therefore presumably 
interacts with the promoter during retinogenesis via chromatin looping (Supplementary Fig. 
10). Second, the remote and primary enhancers drive nearly identical patterns of expression, 
and are thus at least partly redundant (Fig. 7). The two enhancers have no obvious sequence 
similarity, suggesting an independent evolutionary origin, and may have different selective 
constraints. They appear to have evolved as separate entities in the tetrapod lineage, by 
progressive displacement of 5′ regulatory modules from a single ancestral cluster 
(Supplementary Fig. 7c) with refinement by accumulation of point mutations. Third, the 
remote enhancer may be important for evolutionary fitness.
Why does ATOH7 have duplicate enhancers? Each is sufficient for appropriate reporter 
expression in transgenic mice and, although not formally tested, both are likely to be 
necessary for full development of RGCs in vivo. The remote enhancer may greatly boost the 
level of gene expression, acting via a cooperative mechanism, or stabilize the onset of 
transcription at a critical early stage of retinal histogenesis. In principle, delayed 
development of RGCs, due to a disruption in Atoh7 expression or cellular metabolism, could 
prevent ganglion cell axons from exiting the optic cup before closure of the choroid fissure, 
leading to optic nerve hypoplasia and/or coloboma. These effects may be compounded 
because retinal neurogenesis in some vertebrates appears to propagate as a wave, suggesting 
a feed-forward mechanism. This may involve direct binding of Atoh7 protein to E-box sites 
in the proximal enhancer32, although there is no evidence for Atoh7 autoregulation in 
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mammals5. Alternatively, an internal neurogenic timer may be cued by a gradient of 
signaling molecules41. In either model, dual enhancers would assure robust firing of Atoh7 
transcripts.
Congenital optic nerve malformations are relatively common causes of severe visual 
impairment in humans and have environmental and genetic risk factors. Optic nerve 
hypoplasia (ONH) affects 12% of blind children and often occurs with hypothalamic, 
pituitary or other CNS abnormalities (Supplementary Notes). Mutations in several genes are 
known to cause ONH in humans or mice, including Pax6, Pou4f2, Rx, Hesx1, Otx2, Six6, 
Chx10, Sox2, Dcc, Ntn1 and Rpl24. Bilateral optic nerve aplasia is the most extreme ocular 
manifestation of this disease spectrum. There is also considerable variation in optic disc size 
among healthy people42 and RGC number among inbred strains of mice43. In humans, two 
recent genome-wide association studies (GWAS) implicate the ATOH7 region as the most 
important determinant of variation in optic disc area, which is directly related to RGC 
number44,45. Remarkably, the highest statistical significance for this papillometric trait is 
centered over the NCRNA deletion, including one genotyped SNP (rs3858145) in the 
shadow enhancer (Fig. 3c, Supplementary Fig. 8b).
The earliest stages of retinal neurogenesis may be relatively precarious, particularly the brief 
but essential burst of Atoh7 transcription, which is required for vision and thus evolutionary 
survival. In this way, the remote enhancer may buffer this critical process against 
environmental and genetic stresses, as recently demonstrated for the svb and snail loci in 
Drosophila46,47. The dual enhancers appear to function equivalently but have no obvious 
sequence similarity, apart from short motifs (Supplementary Fig. 7). In future studies, it will 
be important to identify the molecular factors that activate these enhancers in vivo, 
triggering the onset of retinal histogenesis, and to determine the transcriptional and 
phenotypic effects of deleting the orthologous remote enhancer in mice.
The NCRNA deletion may silence ATOH7 expression entirely, as a null allele, or prevent 
high-level transcription, similar to deletions of the HBB locus control region or 3′ PAX6 
enhancer. A gain-of-function mechanism is unlikely, since NCRNA heterozygotes are 
normal, and transgenic mice with broad ectopic retinal expression of Atoh7 have no obvious 
histopathology48. Although remote regulatory mutations are known in human genetics, the 
NCRNA deletion provides a clear example of a Mendelian disease involving a duplicate or 
‘shadow’ enhancer.
MATERIALS AND METHODS
Clinical studies
Detailed eye exams and photography were performed on 12 patients for this study at Emam 
Ali Hospital in Bojnourd, North Khorasan. In addition, the findings reflect observations 
from over 40 NCRNA patients examined at regional clinics during the past two decades18. 
Magnetic resonance images (MRI) were obtained for an 18 year-old male subject in Tehran, 
using a Siemens Magnetom Expert-plus instrument. The orbital MRI protocol included T1W 
SE-90, T2 TIR-180, T1 TSE-180 and T1 SE sequences, with fat suppression, before and 
after administration of gadolinium contrast. Images were collected in horizontal, coronal and 
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oblique sagittal planes. Approval was obtained from Shahid Beheshti University Medical 
School and University of Michigan institutional review boards in accordance with accepted 
guidelines.
Mutation screening
Genomic DNA samples from 150 pedigree members were collected as part of a previous 
linkage study19 and include 28 blind subjects. We amplified 184 exonic and 25 intergenic 
fragments from the 14 positional candidates by PCR using custom oligonucleotide primers 
(Supplementary Tables 1–3, Supplementary Fig. 1) and a 2:1 mixture of Platinum Taq 
(Invitrogen) and EXPAND Hi-Fidelity (Roche) polymerases. Segments spanning the GC-
rich ATOH7 gene and 5′ flanking DNA were amplified in the presence of betaine29 as 
detailed (Supplementary Table 1). Screening was performed on a core panel of samples 
from blind (rr), obligate carrier (Rr) and wild-type (RR) individuals. To minimize potential 
effects of chemical inhibitors and DNA damage, a multiple displacement amplification 
(MDA) step (Repli-g, Qiagen) was included before PCR. Products were sequenced directly 
after agarose gel purification (Wizard SV gel system, Promega). Endpoints of the NCRNA 
deletion were determined by junctional PCR, using five different primer pairs. RR 
homozygotes and Rr family members were identified based on previous 10q SSLP 
haplotype analysis20. As expected, blind individuals were homozygous for all SNPs 
surveyed within the nonrecombinant interval.
To determine NCRNA genotypes in family members throughout the pedigree, and identify 
mutation carriers, we used a triplex PCR strategy. Diagnostic reactions (25μl) were 
performed in 1X PCR buffer (50 mM KCl, 20 mM Tris pH 8.4, 1.5 mM MgCl2) containing 
0.3 M betaine (1X MasterAmp™, Epicentre)29, 200 μM dNTPs, 0.25 U Taq polymerase 
(Invitrogen), 75 ng genomic DNA and three primers (5 pmol each). The reverse primers 
were 30R (5′-CCCAGTGTTTCCTAGCTTTGTTAGG) and 37R (5′-
TTCAGAACAGGAGCAGCGTG), and the common forward primer was 30Fref (5′-
TGCAAGGACTTTGTGGCTCTTG). PCRs were performed in a 96-well MJ Thermocycler 
with the following protocol: 95°C × 5 min; followed by 40 cycles of 95°C denaturation × 45 
sec, 55°C annealing × 45 sec, and 72°C extension × 60 sec; followed by a final 72°C 
extension step for 7 min, with termination at 4°C. Allelic wild-type (727 bp) and NCRNA 
deletion (462 bp) products were resolved on a 1% agarose gel.
SNP analysis
Four archival samples from the NCRNA pedigree, and fresh blood and lymphoblastoid cell 
line DNA from one blind (rr) individual, were genotyped for 1.1 million informative SNP 
(single nucleotide polymorphism) markers, distributed with 2.4 kb average spacing genome-
wide, including 390 SNPs in the NCRNA critical interval. Genotypes were determined using 
the Illumina Omni1-quad Infinium BeadChip platform and analyzed for dosage (logR ratio) 
and heterozygosity (B allele frequency) using GenomeStudio software.
Reverse transcriptase (RT)-PCR
Total RNA was isolated from adult retina, liver, kidney and heart tissues and E14.5 fetal 
eyes of C57BL/6 mice by Trizol extraction (Invitrogen) and treated with RNase-free DNase 
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(Roche). cDNA was generated from 5 μg RNA using d(N)6 random hexamers, recombinant 
RT (Superscript II, Invitrogen) and RNaseH in a 40 μl reaction, and 1 μl of the resulting 
cDNA was used as template per 25 μl PCR. Products were amplified for 34 cycles with 
Platinum Taq (Invitrogen) using primers specific for Atoh7, Mypn, Pbld and Actb 
(Supplementary Fig. 3). The PCR cycles were 95°C denaturation × 45 sec, 58°C annealing × 
45 sec, and 72°C extension × 60 sec.
Plasmid constructs
Plasmid p3034-BGnCherry was created by inserting a 3834 bp human genomic fragment 
into the XbaI and BamHI sites of pBGnCherry (kindly provided by Jane Johnson), in the 
normal transcriptional orientation. This vector contains a minimal human β-globin promoter 
(BG) and a monomeric Cherry red fluorescent protein reporter cassette (nuCherry) with a 
synthetic amino-terminal nuclear localization signal (MAPKKKRKVEDV) downstream of 
the BamHI site, and it has no intrinsic activity in transgenic mice. The fragment was 
amplified from human BAC clone RP24-1114I5 with primers 30Fref-SpeI 
(CATTTAACTaGTCAGCTTGCAAGGACTTTGTGGC) and 34R (5′-
GTGAATCAAAGTACAGCATGATGG) and EXPAND Hi-Fidelity polymerase, creating a 
terminal SpeI restriction site. The fragment was purified after digestion with SpeI and 
BamHI, subcloned, and verified by sequencing. It extends between −21.9 kb and −18.1 kb, 
relative to the ATOH7 transcription start site (TSS), and spans three CNEs within the 
NCRNA deletion.
Transgenic mice
Founder embryos and one stable transgenic line were generated by injecting the 5.0 kb SalI-
PspOMI fragment of plasmid p3034-BGnCherry into fertilized (C57 x SJL) F2 or (B6SJL × 
CD-1 Atoh7tm1Gla) F1 oocytes. To directly compare nuCherry and Math5-lacZ expression, 
we examined embryos carrying the Atoh7tm1Gla lacZ knock-in allele5. Math5-GFP mice 
carry an EGFP reporter transgene regulated by a 2.1 kb mouse DNA segment that contains 
the Atoh7 promoter, 5′UTR and 1.8 kb upstream genomic DNA49,31. Embryos from timed 
pregnancies were evaluated for nuCherry and GFP expression by stereofluorescence 
microscopy, or were fixed in 4% paraformaldehyde (PFA), cryosectioned and 
immunostained. To assess cell division, gravid dams were given an intraperitoneal injection 
of BrdU (100 mg/kg) one hour before harvest. Wholemount GFP and nuCherry images were 
obtained using 480/40 or 560/40 nm excitation, and 510 or 610 nm LP emission filters, 
respectively, with a Leica MZ FLIII stereomicroscope.
Immunostaining
Fixed sections or dissociated cells were blocked with 0.5% Triton X-100, 0.1 M NaPO4 pH 
7.3 (PBTx) with 1% bovine serum albumin (BSA) and 10% normal donkey serum (NDS). 
Primary antibodies were applied overnight at 4°C in PBTx with 3% NDS 1% BSA. After 
washing in PBS 0.5% BSA, minimally cross-reactive donkey anti-rabbit IgG sera 
conjugated with biotin (1:500), or donkey anti-chicken IgY or anti-rat IgG sera conjugated 
with Dylight-488 (1:1000, Jackson Immunoresearch, West Grove, PA), was applied for 2 hr 
at room temperature. After secondary antibody staining and washing in PBS 0.5% BSA, 
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tertiary streptavidin-conjugated Texas Red (1:400) or Dylight-594 (1:1000) reagents were 
applied for 1 hr in PBTx with 1 μg/ml 4′,6-diamidino-2- phenylindole (DAPI). Slides were 
then washed in PBS and visualized by epifluorescence (Olympus BX-51) or laser confocal 
microscopy (Zeiss LSM-510). Primary antibodies were anti-DsRed (Clontech rabbit 
polyclonal, 1:500) for Discoma sp. nuCherry; anti-GFP (Abcam chicken polyclonal, 
1:2000); anti-β-galactosidase (rat polyclonal, 1:1000); and anti-BrdU (Harlan BU/175 rat 
monoclonal, 1:100). Genetic and serologic controls showed no cross-detection of nuCherry 
and GFP antigens. BrdU immunostaining was performed as a terminal procedure, following 
application of other 1° and 2° antibodies and an antigen retrieval step (2.4 N HCl in PBS 
0.4% Triton X-100 for 1 hr). PH3 (phosphohistone H3) was detected using polyclonal rabbit 
antibody directly conjugated to Alexa-448 (Cell Signaling 9708, 1:50), after nuCherry 
immunostaining and 10% normal rabbit serum blocking steps, or a mouse monoclonal (6G3, 
Cell Signaling, 1:100) with biotinylated anti-mouse IgG and Alexa-647 streptavidin.
Flow cytometry
Double-positive E14.5 littermates carrying nuCherry and GFP reporters were generated, 
along with single-positive and double-negative controls, by crossing Math5-GFP and 3034-
BGnCherry transgenic mice. Genotypes were provisionally assigned by retinal fluorescence 
and verified by PCR of amniotic membrane DNA. Neural retinas from each embryo were 
dissected in cold PBS and dissociated by digestion with 1 μg/ml trypsin (Gibco) for 15 min 
at 37°C, with intermittant trituration, in a 400 μl volume. The reaction was terminated by 
addition of 1 μg/ml SBTI (soybean trypsin inhibitor, igma), 2.5 mM MgCl2 and 100 μg/ml 
DNase I (Sigma). Freshly dissociated cells were kept on ice, protected from light, and sieved 
immediately prior to flow cytometric analysis by centrifugation at 100×g for 5 min into 70 
μm mesh strainer collection tubes (BD Biosciences).
Two-dimensional flow cytometry was performed using a BD FACS Diva instrument 
equipped with 488 nm argon and 561 nm solid-state excitation lasers (Spectraphysics) and 
510/21 nm and 610/20 nm bandpass emission filters (Omega optics) to detect GFP and 
nuCherry fluorescence, respectively. No spectral compensation was required. Two embryos 
of each genotype (n = 8) were analyzed. For each cell suspension, the primary population 
was gated using FSC-A (forward scatter) and SSC-A (side scatter), and multiparticle events 
were excluded using the FSC-W parameter. Living cells (≥95%) were further gated by 
DAPI (1 μg/ml) exclusion, which was detected using a 351 nm UV laser (Coherent 300) and 
424/44 nm bandpass filter. Flow data from ≥10,000 events were analyzed for each embryo 
using BD FACS Diva software.
To visualize dissociated retinal cells, 20 μl aliquots from each suspension were plated on 8-
well chamber glass slides coated with poly-D-lysine, and the adherent cells were fixed with 
4% PFA. Immunocytochemistry was performed as noted above, with rabbit anti-DsRed 
(1:2000) and chicken anti-GFP (1:5000). Cells were viewed using an Olympus BX-51 
microscope with widefield fluorescence optics and a 100X oil immersion objective.
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Transgenic fish
Zebrafish in our breeding colony originated from a local pet store and are maintained at 
28°C with a 10/14 hour light/dark cycle. Transgenic fish were produced by Tol2 
transposase-mediated integration (Supplementary Notes). Expression cassettes (3034-
BGnCherry and BGnCherry control) were subcloned between the XhoI and BsrGI sites of 
pT2AL200R150G, a plasmid vector that harbors Tol2 transposable elements flanking the 
cloning site. Capped Tol2 transposase mRNA was synthesized from NotI-linearized pCS-TP 
template using the Mmessage Mmachine SP6 kit (Ambion), purified by phenol-chloroform 
extraction, precipitated with isopropanol, and resuspended in nuclease-free water at 1 μg/ml. 
Approximately 0.3 μl of a mixture containing 25 ng/μl supercoiled expression plasmid DNA 
and 25 ng/μl Tol2 transposase mRNA was injected into fertilized zebrafish eggs at the 1–2 
cell stage. Injected embryos were surveyed for nuCherry expression 2–5 days post-
fertilization (dpf) using a Leica MZ FLIII stereofluorescence microscope. No expression 
was detected in embryos injected with the control BGnCherry construct, whereas most 
embryos injected with the 3034-BGnCherry exhibited bright red fluorescence. 
Approximately 100 embryos expressing the reporter were grown to adulthood.
To identify germline integration of the transgene, injected fish were bred in groups of 6–8, 
and their offspring were examined for nuCherry expression. Groups containing fluorescent 
progeny were outcrossed to identify founders (F0) with transgenes integrated in the 
germline. The resulting N1 progeny were then bred to wild- type fish to perpetuate 
heterozygous lines harboring solitary transgenes flanked by LTRs. Three 3034-BGnCherry 
lines were generated in this way. To visualize retinal nuCherry expression in transparent 
embryos, 0.003% 1-phenyl-2-thiourea (PTU) was added to the water at 12 hpf to inhibit 
pigment formation. 3034-BGnCherry progeny were also crossed to the ath5:GFP line 
(kindly provided by Ichiro Masai), which carries a GFP transgene regulated by 7 kb 
genomic DNA from zebrafish ath5 (Supplementary Notes). Mitotic cells were labeled by 
immersing zebrafish embryos for 20 min in 1 mM EdU (ethynyl deoxyuridine) 15% DMSO 
prior to fixation in 4% PFA and cryopreservation. EdU-labeled nuclei were detected using 
CuSO4 and Alexafluor 647 azide (Click-iT reagents, Invitrogen).
Informatics
Sequence comparisons were performed between remote and primary ATOH7 enhancer 
elements in human and mouse genomes using pairwise BLAST (http://
blast.ncbi.nlm.nih.gov/Blast.cgi). Upstream ATOH7 regulatory regions from diverse taxa 
were aligned using pairwise (BLASTZ), MultiZ and PhastCons features of the UCSC 
browser (http://genome.ucsc.edu), for panels containing 12 eutherian mammals and 37 
vertebrate species (Supplementary notes) and mVISTA (LAGAN). To search for 
homologous amphibian and fish sequences, we interrogated Xenopus, teleost (Danio, 
Oryzias, Gasterosteus, Tetraodon) and lamprey (Petromyzon) genomes and upstream 
regions with individual CNE segments from the NCRNA deletion, using high- and low-
stringency search parameters. PCR sequence analysis and optimal primer design for 
mutation screening were performed using MacVector 7.2 software (Accelrys). For mutation 
screening, PCR sequences from the NCRNA pedigree were compared to the NCBI reference 
genome (NCBI36/hg18, Mar 2006 assembly) and known variants (dbSNP, including the 
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March 2010 interim release from the 1000 genomes project). Potential regulatory motifs for 
DNA-binding factors were identified using multiple analysis tools, including the JASPAR 
database (http://jaspar.genereg.net/).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
NCRNA disease. A–F. Eye photographs from NCRNA family. A. 49-yr old female B. 18-yr 
old male C. 14-yr old female D. 8-yr old male. Retinal detachments are evident as 
leukocoria (white pupils) in each case. The NCRNA patients eventually develop dense gray 
posterior corneal opacities, consistent with chronic blood staining (A, B, patient’s right eye 
in C). They typically exhibit nystagmus and strabismus (esotropia, D). The pupils are round, 
but do not react to light. E–F. Closer views showing leukocoria in young patients prior to 
corneal opacification. E. 5-yr old male (left eye). F. 3-yr old male (left eye). The detached 
retina and fibrovascular mass are visible behind the clear lens (arrow). G. Khorasani 
pedigree showing autosomal recessive inheritance of the disease over nine generations, with 
index cases used for mutation screening (red boxes).
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Figure 2. 
Anatomical findings in NCRNA. A–C. Orbital magnetic resonance images (MRI) of an 18-
yr old male patient, showing absence or severe atrophy of the optic nerves and chiasm (red 
arrowheads), and bilateral detached retinas with vitreous consolidation (bright signal, blue 
arrowheads). A. Axial (TR/TE = 780/15 ms, 3 mm slices) and B. Oblique sagittal (right eye, 
TR/TE = 730/15 ms, 2 mm slice) T1-weighted SE views, with fat suppression and 
gadolinium contrast. C. Coronal T1-weighted SE views (TR/TE = 780/15, 5 mm slices) with 
no contrast or fat suppression, shown from anterior (left) to posterior (right). D. Matched 
coronal images from a normal 15-yr old female. T1-weighted SE views (TR/TE = 550/11 
ms, 3 mm slices). The vitreae are clear (left panel, dark signal, blue arrowhead) and the optic 
nerves are prominent (middle panels, red arrowheads). The optic chiasm is visible above the 
suprasellar cistern and pituitary (right panel, red arrowhead). E. Matched axial images from 
the normal subject (TR/TE = 750/11 ms, 3 mm slices). F,G. Enlarged coronal views of 
NCRNA and normal subjects (left orbits, boxed areas in panels C and D). The red 
arrowhead shows the normal optic nerve. The bright T1W signal outlining the optic nerve, 
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extraocular muscles (sr, lr, ir, mr, so, lps) and blood vessels (sov) originates from retrobulbar 
fat. 3v, third ventricle; cc, corpus callosum; cis, suprasellar cistern; eth, ethmoid sinus; hyp, 
hypothalamus; ica, internal carotid artery; io, inferior oblique; ir, inferior rectus; la, levator 
aponeurosis; lg, lacrimal gland; lps, levator palpebrae superioris; lr, lateral rectus; lv, lateral 
ventricle; max, maxillary sinus; mr, medial rectus; nph, nasopharynx; oa, ophthalmic artery; 
oc, optic canal; on, optic nerve; pit, pituitary gland; po, pons; ps, pituitary stalk; so, superior 
oblique; sov, superior orbital vein; sph, sphenoid sinus; sr, superior rectus; st, sella turcica; 
tem, temporal lobe; vit, vitreous; x, optic chiasm.
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Figure 3. 
Homozygous deletion of 5′ ATOH7 genomic sequences in NCRNA patients. A. The 1639 kb 
critical region on chromosome 10q21 spans 14 positional candidate genes. The segment 
between PBLD to MYPN (blue bracket) is expanded below. B. Genomic PCRs showing 
deletion of four adjacent amplicons in an NCRNA patient. Two additional amplicons were 
also missing (Supplementary Table 3). C. Map of 74 kb intergenic region surrounding 
ATOH7 (Chr10:69,714,052–69,640,048) modified from the UCSC browser (NCBI36/hg18, 
Mar 2006 assembly), showing the terminal exons of flanking genes; KRTψ (human-specific 
keratin-18 pseudogene); vertebrate and mammalian evolutionary conservation tracks 
(PhastCons); interspersed repetitive elements; PCR amplicons (red) used to compare 
homozygous mutant (rr) and wild-type (RR) DNA samples; and the 6.5 kb NCRNA 
deletion. Orthologous vertebrate sequences are indicated in the vertebrate MultiZ alignment. 
In the nontherian genomes, similarity between KRTψ and unlinked keratin loci gives a false 
positive signal of homologous evolution. The corresponding mouse Pbld-Mypn intergenic 
segment is 42.5 kb. Two SNPs (single nucleotide polymorphisms) associated with optic disc 
area in human genome-wide studies44,45 are indicated for comparison (rs1900004, 
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rs3858145). The deletion removes a cluster of CNEs (conserved noncoding elements) ~20 
kb upstream of ATOH7.
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Figure 4. 
Endpoints of the NCRNA deletion. A. Triplex PCR genotypes showing transmission of the 
mutation in a small family. B. Sequence chromatograms from PCR products showing the 
distal and proximal breakpoints in wild-type DNA, with 5 bp microhomology (double 
arrow), and the deletion junction in a DNA from a blind individual.
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Figure 5. 
The NCRNA mutation deletes an ATOH7 retinal enhancer. A. Map of the 30kb upstream 
region (Chr10:69,690,000–69,660,000) modified from the UCSC browser (NCBI36/hg18, 
Mar 2006 assembly), showing mammalian basewise sequence conservation and the NCRNA 
deletion. The 3034-BGnCherry transgene contains 3.8 kb human genomic DNA, which 
spans the three deleted CNEs and regulates expression from the minimal human β-globin 
promoter. The location of the Math5-GFP transgene is shown for comparison. This reporter 
contains the endogenous mouse Atoh7 promoter, 0.3 kb 5′UTR and 1.8 kb upstream 
genomic DNA31. B–E. Brightfield (B,C) and fluorescence (D,E) images show eye-specific 
nuCherry expression in a pigmented E13.5 transgenic founder. Tg, transgenic.
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Figure 6. 
Activity of the remote ATOH7 retinal enhancer in 3034-BGnCherry mice. Double transgenic 
3034-BGnCherry; Math5-lacZ/+ embryos were exposed to BrdU, harvested between E12 
and E16, cryosectioned, and immunostained for nuCherry (red) and β-galactosidase, BrdU 
or phosphohistone H3 (green). A,B,E. The nuclear 3034- BGnCherry and cytoplasmic 
Math5-lacZ patterns are essentially overlapping, with >85% cell concordance (not shown). 
However, the subcellular localizations differ, with accumulation of βgal in RGC axons at the 
inner retinal surface and nascent optic nerve (open arrowheads). C,D,F–H. The 3034-
BGnCherry transgene is expressed in post-mitotic retinal cells, with no overlap between 
nuCherry and the mitotic markers BrdU (S-phase) or PH3 (M-phase). Closed arrowheads 
mark the apical (sclerad) side in E–H. Scale bars: 40 μm in A; 20 μm in D; and 10 μm in E–
H.
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Figure 7. 
Remote and primary ATOH7 enhancers have similar activity in the developing mouse retina. 
Coexpression of nuCherry and GFP transgenes. A–B. Double transgenic 3034-BGnCherry; 
Math5-GFP embryos immunostained for both reporters. Low (A) and confocal high (B) 
magnification views of E11.5 to E16.5 retinal sections. The onset and expression patterns of 
the transgenes are essentially overlapping. C. Two-dimensional flow cytometric analysis of 
dissociated E14.5 retinal cells from 3034-BGnCherry × Math5-GFP littermate embryos 
carrying one, neither or both transgenes. The percentage of cells in each quadrant is 
indicated in the contour plots. The concordance between nuCherry and GFP fluorescence is 
high. Double-positive cells represent ~40% of the neural retina in 3034-BGnCherry; Math5-
GFP embryos (upper right). D. Dissociated cells from an E14.5 double transgenic embryo 
immunostained for nuCherry and GFP. Arrowheads in B mark the apical side. Scale bars: 40 
μm in A; 20 μm in B; and 10 μm in D.
Ghiasvand et al. Page 27
Nat Neurosci. Author manuscript; available in PMC 2011 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 8. 
The human remote ATOH7 enhancer functions in developing zebrafish. A,B. Lateral and 
dorsal views of live embryos showing specific retinal expression of the 3034-BGnCherry 
transgene in progenitor cells at 72 hpf development. C–E. Transverse sections of 
immunostained 3034-BGnCherry; ath5:GFP embryos showing colocalized expression of 
nuCherry and GFP in the retina at 48, 72 and 128 hpf, with perdurance of reporter proteins 
in RGCs. The cytoplasmic GFP also labels RGC axons in the optic nerves, chiasm and tracts 
projecting to the thalamus and tectum. g, ganglion cell layer; hb, habenula; i, inner nuclear 
layer; o, outer nuclear layer; on, optic nerve; rtt, retinotectal tract; tel, telencephalon; th, 
thalamus; hpf, hours post fertilization. Scale bars, 50 μm.
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